Description

2-[3-(2-Chlorophenyl)-6-Oxopyridazin-1(6H)-Yl]-n-(1,1-Dioxidotetrahydrothiophen-3-Yl)-n-Methylacetamide is a high-purity synthetic organic compound featuring a complex heterocyclic structure. This molecule is of significant commercial interest as a key pharmaceutical intermediate or advanced research chemical. It is primarily sought by R&D and process development teams in the pharmaceutical and biotechnology sectors for the synthesis of novel active pharmaceutical ingredients (APIs). The compound's specific structure suggests potential utility in medicinal chemistry programs targeting neurological or metabolic pathways.

Application

• Pharmaceutical Intermediate: Serves as a critical building block in the multi-step synthesis of novel drug candidates, particularly in central nervous system (CNS) or metabolic disease research.
• Medicinal Chemistry Research: Used as a core scaffold or precursor for structure-activity relationship (SAR) studies to optimize potency and selectivity of lead compounds.
• Process Development & Scale-Up: Employed in pilot plants and kilo-labs for developing and optimizing robust, scalable synthetic routes for API manufacturing.
• Contract Research & Manufacturing (CRO/CMO): Supplied to service organizations supporting pharmaceutical companies with custom synthesis and process development.
• Biochemical Tool Compound: May be utilized in vitro as a probe to study specific enzyme inhibition or receptor modulation in early-stage discovery.
• Reference Standard: Provides a high-purity benchmark for analytical method development, validation, and quality control during API production.

Basic Information

Product Name	2-[3-(2-Chlorophenyl)-6-Oxopyridazin-1(6H)-Yl]-n-(1,1-Dioxidotetrahydrothiophen-3-Yl)-n-Methylacetamide
CAS No.	1232792-31-2
Molecular Formula	C17H18ClN3O4S
Molecular Weight	395.86 g/mol
Synonyms	2-[3-(2-Chlorophenyl)-6-oxopyridazin-1(6H)-yl]-N-(1,1-dioxidotetrahydrothiophen-3-yl)-N-methylacetamide; 2-(3-(2-Chlorophenyl)-6-oxopyridazin-1(6H)-yl)-N-(1,1-dioxidotetrahydrothiophen-3-yl)-N-methylacetamide; UNII-6Q6F6K8Q4P; 6Q6F6K8Q4P; 2-[3-(2-chlorophenyl)-6-oxo-1,6-dihydropyridazin-1-yl]-N-(1,1-dioxo-1lambda6-thiolan-3-yl)-N-methylacetamide; Acetamide, 2-[3-(2-chlorophenyl)-6-oxo-1,6-dihydropyridazin-1-yl]-N-(1,1-dioxo-1lambda6-thiolan-3-yl)-N-methyl-
EINECS	Contact for details

Quality Control

Our production of 2-[3-(2-Chlorophenyl)-6-Oxopyridazin-1(6H)-Yl]-n-(1,1-Dioxidotetrahydrothiophen-3-Yl)-n-Methylacetamide adheres to stringent quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity, NMR and MS for structural confirmation, and rigorous control of residual solvents and impurities. Certificates of Analysis (COA) detailing all specifications and test results are provided and can be tailored to meet specific client or regulatory requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, well-ventilated area at controlled room temperature (15-25°C). The compound may be hygroscopic (moisture-sensitive); keep the container tightly sealed in a dry environment.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residual Solvents (GC)	Complies with ICH Q3C guidelines
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.